Mind Medicine (MindMed) Inc
NASDAQ:MNMD

Watchlist Manager
Mind Medicine (MindMed) Inc Logo
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Watchlist
Price: 6.74 USD -1.46%
Market Cap: 509.2m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

MNMD Price Targets Summary
Mind Medicine (MindMed) Inc

Wall Street analysts forecast MNMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MNMD is 25.76 USD with a low forecast of 16.16 USD and a high forecast of 57.75 USD.

MNMD Lowest Forecast
Wall Street Target
16.16 USD
140% Upside
MNMD Average Forecast
Wall Street Target
25.76 USD
282% Upside
MNMD Highest Forecast
Wall Street Target
57.75 USD
757% Upside
Lowest
Price Target
16.16 USD
140% Upside
Average
Price Target
25.76 USD
282% Upside
Highest
Price Target
57.75 USD
757% Upside
Mind Medicine (MindMed) Inc Competitors:
Price Targets
4519
Chugai Pharmaceutical Co Ltd
15% Upside
D
086450
Dongkook Pharmaceutical Co Ltd
53% Upside
PFIZER
Pfizer Ltd
12% Upside
RAPP
Rapport Therapeutics Inc
202% Upside
4519
Chugai Pharmaceutical Co Ltd
15% Upside
D
086450
Dongkook Pharmaceutical Co Ltd
53% Upside
PFIZER
Pfizer Ltd
12% Upside
RAPP
Rapport Therapeutics Inc
202% Upside
002653
Haisco Pharmaceutical Group Co Ltd
43% Upside
ALKEM
Alkem Laboratories Ltd
8% Upside
TBPH
Theravance Biopharma Inc
62% Upside
2070
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
9% Upside

Revenue
Forecast

Revenue Estimate
Mind Medicine (MindMed) Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Mind Medicine (MindMed) Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Mind Medicine (MindMed) Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-63%
Average Miss
What are analyst estimates?

See Also

Summary
MNMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
MNMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MNMD stock valuation using valuation multiples.
Wall Street Estimates
MNMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MNMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MNMD's stock price target?
Price Target
25.76 USD

According to Wall Street analysts, the average 1-year price target for MNMD is 25.76 USD with a low forecast of 16.16 USD and a high forecast of 57.75 USD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 264,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.